News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Switch from complex to single-tablet regimen does not compromise HIV suppression
01 Oct 2026
byStephen Padilla
Treatment with the single-tablet regimen (STR) doravirine/islatravir (DOR/ISL; 100/0.25 mg) results in sustained virologic suppression in almost all virologically suppressed adults with HIV-1 receiving complex antiretroviral therapy (ART) regimens, a study has shown.
01 Oct 2026







